Results 11 to 20 of about 8,785 (193)

Flumazenil [PDF]

open access: yes, 2020
Flumazenil; Intoxicació; BenzodiazepinesFlumazenil; Intoxicación; BenzodiacepinasFlumazenil; Intoxication; BenzodiazepinesArticle sobre el flumazenil: antídot específic per revertir la depressió del sistema nerviós central (SNC) causada per una ...
Grup de Treball Xarxa d’Antídots   +2 more
core   +3 more sources

Delayed Flumazenil Injection after Endoscopic Sedation Increases Patient Satisfaction Compared with Immediate Flumazenil Injection

open access: yesGut and Liver, 2014
Background/AimsFlumazenil was administered after the completion of endoscopy under sedation to reduce recovery time and increase patient safety. We evaluated patient satisfaction after endoscopy under sedation according to the timing of a postprocedural ...
doaj   +2 more sources

Update on Sedation for Upper Gastrointestinal Endoscopy in Japan: Current Evidence on Remimazolam. [PDF]

open access: yesDEN Open
ABSTRACT Sedation is an essential component of upper gastrointestinal endoscopy because it reduces patient discomfort and anxiety while improving patient acceptance and procedural quality. In Japan, benzodiazepines such as midazolam and opioid analgesics have long been widely used in routine clinical practice; however, many of these agents historically
Ichijima R   +13 more
europepmc   +2 more sources

Remimazolam for Zephyr Endobronchial Valve Placement in a Severe Chronic Obstructive Pulmonary Disease Patient: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Remimazolam‐based general anesthesia provided stable hemodynamics and rapid, clear emergence in a patient with severe chronic obstructive pulmonary disease undergoing Zephyr endobronchial valve placement, suggesting that remimazolam may be a feasible anesthetic option for this procedure in patients with limited cardiopulmonary reserve.
Morimoto T   +7 more
europepmc   +2 more sources

Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal? [PDF]

open access: yes, 2022
Introduction: Benzodiazepines (BZDs) are used in the management of anxiety and sleep disorders; however, chronic use is associated with tolerance and dependence. During withdrawal, symptoms of anxiety are often severe and problematic for patients and may
Alexander Gallo   +9 more
core   +1 more source

Comparison of Remimazolam-Flumazenil and Propofol on Psychomotor Function and Emergence Following General Anesthesia in Surgical Abortion: A Randomized Controlled Trial [PDF]

open access: yesDrug Design, Development and Therapy
Jinye Gu,1,* Yang Liu,1,* Xiaoyan Lin,1 Lei Fu,1 Jianbo Liu,1 Bona Sun,2 Xiaoyu Li,3 Bo Lu3 1Department of Anesthesiology, Zhenhai Hospital of Traditional Chinese Medicine, Ningbo, 315200, People’s Republic of China; 2Department of Gynaecology ...
Gu J   +7 more
doaj   +1 more source

A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept

open access: yes, 2022
INTRODUCTION: Benzodiazepines (BZD) are a class of anxiolytics with varying uses, which primarily act on the GABAA receptor resulting in hyperpolarisation.
Hulse, GK   +4 more
core   +1 more source

Flumazenil-Insensitive Benzodiazepine Effects in Recombinant αβ and Neuronal GABAA Receptors

open access: yesBrain Sciences, 2020
Gamma-aminobutyric acid, type A (GABAA) receptors are complex heterogeneous pentamers with various drug binding sites. Several lines of evidence suggest that benzodiazepines modulate certain GABAA receptors in a flumazenil-insensitive manner, possibly ...
Jing-Jing Lian   +4 more
doaj   +1 more source

Automated Synthesis of [18F]Flumazenil Application in GABAA Receptor Neuroimaging Availability for Rat Model of Anxiety

open access: yesPharmaceuticals, 2023
Clinical studies have demonstrated that the γ-aminobutyric acid type A (GABAA) receptor complex plays a central role in the modulation of anxiety.
Shiou-Shiow Farn   +5 more
doaj   +1 more source

Re-audit of the use of flumazenil following midazolam-induced conscious sedation

open access: yesBDJ Open, 2023
Introduction Flumazenil is an antagonist drug of Benzodiazepam (BDZ) that has been used as a reversal agent of midazolam-induced conscious sedation (CS) in both emergency and elective procedures.
Muhammad Syafiq Asyraf Rosli   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy